Apixaban Nitroso Impurity 7 - Request Quote
Apixaban Nitroso Impurity 7
| SZ CAT No: | SZ-A062142 |
| CAS No | NA |
| Mol.F. | C25H27N7O5 |
| Mol.Wt. | 505.5 |
| Inv. Status | Limited Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Apixaban Nitroso Impurity 7 is chemically 1-(4-Methoxyphenyl)-4-(2-(nitroso(4-(2-oxopiperidin-1-yl)phenyl)amino)ethyl)-1H-pyrazole-3,5-dicarboxamide. Apixaban Nitroso Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Nitroso Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Apixaban Nitroso Impurity 7
Purchase Apixaban Nitroso Impurity 7
Apixaban Nitroso Impurity 7 suppliers
Apixaban Nitroso Impurity 7 manufacturers
Apixaban Nitroso Impurity 7 price
Order Apixaban Nitroso Impurity 7
Enquire Apixaban Nitroso Impurity 7
Apixaban Nitroso Impurity 7 cost
Apixaban Nitroso Impurity 7 Supplier
Apixaban Nitroso Impurity 7 Distributor
Apixaban Nitroso Impurity 7 for Method Validation
Apixaban Reference Standard
Apixaban Nitroso Impurity 7 for ANDA Filing
Apixaban Nitroso Impurity 7 for Forced Degradation Studies
Apixaban Nitroso Impurity 7 Identification Standards
Apixaban Nitroso Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.